Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

Jurjen Versluis, F t Hout, RMH (Raynier) Devillier, WLJ van Putten, MG Manz, MC Vekemans, MC Legdeur, JR Passweg, J Maertens, J Kuball, BJ Biemond, Peter Valk, BA van der Reijden, G Meloni, HC Schouten, E Vellenga, T Pabst, R Willemze, Bob Löwenberg, G OssenkoppeleF Baron, G Huls, Jan Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

56 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)26-33
Number of pages8
Issue number1
Publication statusPublished - 2017

Research programs

  • EMC MM-02-41-03

Cite this